The article, “ivWatch Finds Strong Ally in Philips to Monitor Peripheral IVs” introduces the scope of the complications associated with peripheral IV failure. The piece goes on to highlight the ivWatch Model 400 compatibility with Philips Patient Monitors and the potential to offer time-saving benefits, where ivWatch President and CEO, Gary Warren, touches on the need for more patients to have access to technology for early detection of peripheral IV infiltration, allowing for earlier intervention by the clinician. Read the full article here.
In the News: ivWatch Finds Strong Ally in Philips to Monitor Peripheral IVs
